Related Experiment Videos

Physician-pharmacist comanagement of hypertension: a randomized, comparative trial

Jeff E Borenstein1, Geneen Graber, Emmanuel Saltiel

  • 1Department of Medicine, Cedars-Sinai Health System, Beverly Hills, California 90212, USA. jeff.borenstein@cshs.org

Pharmacotherapy
|February 18, 2003
PubMed

Insights

Physician-pharmacist comanagement significantly improved blood pressure control in patients with uncontrolled hypertension. This systematic approach also reduced healthcare costs compared to usual care.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Pharmacy
  • Primary Care

Background:

  • Uncontrolled hypertension remains a significant public health challenge.
  • Effective management strategies are crucial for preventing cardiovascular complications.
  • Current hypertension care models may not fully optimize patient outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of a physician-pharmacist comanagement (PPCM) model versus usual care (UC) for uncontrolled hypertension.
  • To compare blood pressure reduction and control rates between PPCM and UC groups.
  • To assess the impact of PPCM on healthcare visit costs.

Main Methods:

  • Randomized controlled trial involving patients with uncontrolled hypertension.
  • Intervention group received physician-pharmacist comanagement; control group received usual care.
  • An evidence-based hypertension treatment algorithm guided the PPCM approach.

Main Results:

  • Both groups showed significant blood pressure reduction, but PPCM yielded a greater systolic reduction (p < 0.01).
  • A higher percentage of patients achieved blood pressure control in the PPCM group (60% vs 43%, p = 0.02).
  • Average provider visit costs per patient were lower in the PPCM group ($160 vs $195, p = 0.02).

Conclusions:

  • Evidence-based physician-pharmacist comanagement enhances blood pressure control in hypertensive patients.
  • The PPCM model is a cost-effective strategy for managing uncontrolled hypertension.
  • Systematic, team-based care improves patient outcomes and reduces healthcare expenditures.
Abstract

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...